Randomized, Placebo-Controlled Trial of Rifaximin Therapy for Lowering Gut-Derived Cardiovascular Toxins and Inflammation in CKDCassandra Kimber, Jason R. Stubbs, Cassandra Johnson et al.|Kidney360|2020Cited by 22